Genetic screening for neovascular AMD: cost effective…not so quick
نویسنده
چکیده
The following is a response to Brown and colleagues (Int J Retin Vitr 1:19, 2015), who analyzed the cost effectiveness of genetic screening for neovascular AMD in Category 3 (intermediate). As explained in this letter, it is premature to propose that genetic screening is cost effective in this setting. A simple clinical history and macular exam is highly cost effective and can easily guide screening strategies.
منابع مشابه
A Value-Based Medicine cost-utility analysis of genetic testing for neovascular macular degeneration
BACKGROUND There is a dearth of patient, preference-based cost-effectiveness analyses evaluating genetic testing for neovascular age-related macular degeneration (NVAMD). METHODS A Value-Based Medicine, 12-year, combined-eye model, cost-utility analysis evaluated genetic testing of Category 3 AMD patients at age 65 for progression to NVAMD. The benefit of genetic testing was predicated upon t...
متن کاملGenetic association study of mitochondrial polymorphisms in neovascular age-related macular degeneration
PURPOSE Age-related macular degeneration (AMD) is a multifactorial disease involving genetic and environmental factors. Most of the genetic factors identified so far involve the nuclear genome. Recently, two studies in North America and Australia reported an association between advanced AMD and the mitochondrial T2 haplogroup. Our purpose was to assess this association in a large French populat...
متن کاملCost-effectiveness of autologous retinal pigment epithelium and choroid translocation in neovascular AMD.
AIM To assess the cost-effectiveness of autologous retinal pigment epithelium and choroid translocation (PATCH) in neovascular age-related macular degeneration (AMD). METHODS Visual acuity and complication rates of published patient series were used to determine the incremental utility of treatment for the patient. The utility data applied assume that the better eye was affected. Comparator w...
متن کاملEthnic differences in the association of SERPING1 with age-related macular degeneration and polypoidal choroidal vasculopathy
Neovascular age-related macular degeneration (AMD) and polypoidal choroidal vasculopathy (PCV) are leading causes of irreversible blindness in developed countries. In this study, we investigated the association of single nucleotide polymorphisms (SNPs) in the serpin peptidase inhibitor, clade G, member 1 (SERPING1) gene with neovascular AMD and PCV. Two haplotype-tagging SNPs, rs1005510 and rs1...
متن کاملPharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation.
OBJECTIVE To examine the economic implications for the Canadian health system of pharmacologic treatment of neovascular age-related macular degeneration (AMD). DESIGN Systematic review of economic literature and a primary economic evaluation. PARTICIPANTS Economic literature search identified 392 potentially relevant articles, 12 of which were included for final review. METHODS Studies we...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره 1 شماره
صفحات -
تاریخ انتشار 2015